Compare Japan Lifeline Co., Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a 4.36% CAGR growth in Operating Profits over the last 5 years
2
Poor long term growth as Operating profit has grown by an annual rate 4.36% of over the last 5 years
3
Flat results in Mar 26
4
With ROE of 14.58%, it has a very attractive valuation with a 1.45 Price to Book Value
5
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
JPY 98,537 Million (Small Cap)
10.00
NA
0.00%
-0.14
14.62%
1.50
Revenue and Profits:
Net Sales:
14,782 Million
(Quarterly Results - Mar 2026)
Net Profit:
2,529 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
7.92%
0%
7.92%
6 Months
8.15%
0%
8.15%
1 Year
6.48%
0%
6.48%
2 Years
45.11%
0%
45.11%
3 Years
37.21%
0%
37.21%
4 Years
49.85%
0%
49.85%
5 Years
12.42%
0%
12.42%
Japan Lifeline Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
2.25%
EBIT Growth (5y)
4.36%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
0.88
Tax Ratio
24.46%
Dividend Payout Ratio
40.51%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
22.76%
ROE (avg)
14.21%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.45
EV to EBIT
7.05
EV to EBITDA
6.20
EV to Capital Employed
1.49
EV to Sales
1.48
PEG Ratio
0.90
Dividend Yield
NA
ROCE (Latest)
21.17%
ROE (Latest)
14.58%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
14,782.00
15,120.00
-2.24%
Operating Profit (PBDIT) excl Other Income
3,205.00
3,611.00
-11.24%
Interest
6.00
10.00
-40.00%
Exceptional Items
-227.00
-102.00
-122.55%
Consolidate Net Profit
2,529.00
2,047.00
23.55%
Operating Profit Margin (Excl OI)
188.10%
211.20%
-2.31%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -2.24% vs 3.07% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 23.55% vs -17.19% in Dec 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
59,187.00
56,610.00
4.55%
Operating Profit (PBDIT) excl Other Income
14,360.00
14,617.00
-1.76%
Interest
34.00
36.00
-5.56%
Exceptional Items
-145.00
-335.00
56.72%
Consolidate Net Profit
9,350.00
9,317.00
0.35%
Operating Profit Margin (Excl OI)
209.30%
221.20%
-1.19%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 4.55% vs 10.17% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 0.35% vs 23.98% in Mar 2025
About Japan Lifeline Co., Ltd. 
Japan Lifeline Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






